Selection in context: patterns of natural selection in the glycoprotein 120 region of human immunodeficiency virus 1 within infected individuals

Genetics
A R TempletonRichard B Markham

Abstract

Evolution of the HIV-1 V3 loop was monitored in 15 subjects over a period of 5 years at approximately 6-month intervals. Putative recombination was detected in many of the sequences. Evolutionary trees were estimated from the nonrecombinant viral sequences found in each individual. Selection and altered demographic regimes were detected with logit and other contingency analyses in a highly context-dependent fashion. Mutations leading to amino acid substitutions are subject to positive selection over a broad range of clinical conditions in the nonsyncytium-inducing (NSI) form, and the growth rates of the NSI strains and their level of genetic subdivision change little in going from a healthy immune system to a severely compromised immune system. In contrast, the SI form has a significant increase in growth rate as the immune system goes from healthy to compromised, particularly in those subjects who did not receive any antiviral drug therapy. This increase in SI growth rate results in a significant growth advantage of SI over NSI when the immune system is compromised. The SI strains also show more demographic subdivision when the immune system is healthy than when the immune system is compromised, and the SI form has greater dem...Continue Reading

References

Jun 20, 1991·Nature·J H McDonald, M Kreitman
Feb 12, 1971·Nature·M Kimura, T Ohta
Jul 13, 1995·Nature·S BonhoefferM A Nowak
Jan 1, 1994·Annual Review of Genetics·F Seillier-MoiseiwitschR Swanstrom
Jun 1, 1994·Molecular Phylogenetics and Evolution·J Castelloe, A R Templeton
Mar 1, 1993·Genetics·Y X Fu, W H Li
May 1, 1996·Molecular Biology and Evolution·T EndoT Gojobori
Feb 6, 1997·Nature·M T DittmarP Simmonds
Feb 18, 1997·Proceedings of the National Academy of Sciences of the United States of America·Y Yamaguchi, T Gojobori
Oct 15, 1998·Proceedings of the National Academy of Sciences of the United States of America·R B MarkhamX F Yu
May 20, 1999·Molecular Biology and Evolution·E C HolmesA Rambaut
Jan 13, 2000·American Journal of Human Genetics·A R TempletonC F Sing
Feb 29, 2000·Proceedings. Biological Sciences·D S CallawayM A Nowak
Oct 12, 2000·Proceedings of the National Academy of Sciences of the United States of America·H XiaoK T Jeang
Mar 10, 2001·Cell·S Rowland-JonesR Kaul
Feb 13, 2003·International Journal of Behavioral Medicine·M P CarrieriUNKNOWN MANIF Study Group
Apr 8, 2003·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Anita PalepuJulio S G Montaner

❮ Previous
Next ❯

Citations

Feb 3, 2006·Molecular Biology and Evolution·Antonio Carvajal-RodríguezDavid Posada
May 23, 2006·BMC Evolutionary Biology·Takahisa OkabayashiCatherine Walton
Jun 6, 2009·Retrovirology·Alan R TempletonRichard B Markham
Feb 4, 2010·PLoS Computational Biology·Richard A Neher, Thomas Leitner
Dec 13, 2005·Proceedings of the National Academy of Sciences of the United States of America·Simon D W FrostDouglas D Richman
Aug 9, 2006·Evolution; International Journal of Organic Evolution·Daniel ShrinerJames I Mullins
Oct 3, 2012·Evolution; International Journal of Organic Evolution·Jack da Silva
Dec 6, 2011·Molecular Phylogenetics and Evolution·Eduardo Castro-NallarKeith A Crandall
Feb 6, 2008·Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases·Antonio Carvajal-RodríguezKeith A Crandall

❮ Previous
Next ❯

Related Feeds

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.